Identification of a potent and selective 5-HT1B receptor antagonist

Bioorganic and Medicinal Chemistry Letters

Volumn 15, Issue 21, 2005, Pages 4708-4712

  Wyman, Paul A ^a   Marshall, Howard R ^a   Flynn, Sean T ^a   King, Ron J ^a   Thompson, Mervyn ^a   Smith, Paul W ^a   Hadley, Michael S ^a   Price, Gary W ^a   Scott, Claire M ^a   Dawson, Lee A ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

5 HT1B receptor antagonist; SB 616234

Indexed keywords

SB 616234; SEROTONIN 1A RECEPTOR; SEROTONIN 1B ANTAGONIST; SEROTONIN 1D RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; DRUG ACTIVITY; DRUG IDENTIFICATION; DRUG SELECTIVITY; DRUG STRUCTURE; STRUCTURE ACTIVITY RELATION;

ANIMALS; HUMANS; LIGANDS; MICROSOMES, LIVER; RATS; RECEPTOR, SEROTONIN, 5-HT1B; SEROTONIN ANTAGONISTS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 25144440042     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2005.07.085     Document Type: Article

References (22)

1. P.R. Hartig, D. Hoyer, P.P. Humphrey, and G.R. Martin Trends Pharmacol. Sci. 17 1996 103
2. D. Hoyer, J.P. Hannon, and G.R. Martin Pharmacol. Biochem. Behav. 71 2002 533
3. C. Roberts, and G.W. Price Neurosci. Lett. 300 2001 45
4. C. Roberts, G.W. Price, and D.N. Middlemiss Brain Res. Bull. 56 2001 463
5. J.A. Stamford, D. Davidson, D.P. McLaughlin, and S. Hopwood Trends Neurosci. 23 2000 459
6. D.N. Middlemiss, M. Gothert, E. Schlicker, C.M. Scott, J.V. Selkirk, J. Watson, L.M. Gaster, P. Wyman, G. Riley, and G. Price Eur. J. Pharmacol. 375 1999 359
7. C. Roberts, D.F. Boyd, D.N. Middlemiss, and C. Routledge Neuropharmacology 38 1999 1409
8. C. Roberts, P. Hatcher, J.J. Hagan, P. Jeffrey, P. Wyman, L.M. Gaster, and D.N. Middlemiss Naunyn-Schmiedebergs Arch. Pharmacol. 362 2000 177
9. J.W. Clitherow, D.I.C. Scopes, M. Skingle, C.C. Jordan, W. Feniuk, I.B. Campbell, M.C. Carter, E.W. Collington, H.E. Connor, G.A. Higgins, D. Beattie, H.A. Kelly, W.L. Mitchell, A.W. Oxford, A.H. Wadsworth, and M.B. Tyers J. Med. Chem. 37 1994 2253
10. Clitherow, J. W.; King, F. D.; Middlemiss, D. N.; Wyman, P. A. In Progress in Medicinal Chemistry; King, F. D.; Oxford, A. W., Eds.; Elsevier Amsterdam. 2003, Vol. 41, pp 129-165.
11. A. Slassi Curr. Top. Med. Chem. 2 2002 559
12. N.M. Barnes, and T. Sharp Neuropharmacology 38 1999 1083
13. P.J. Pauwels CNS Drugs 2 1996 415
14. P.J. Pauwels, and F.C. Colpaert Neuropharmacology 34 1995 235
15. P.J. Pauwels, C. Palmier, T. Wurch, and F.C. Colpaert Naunyn-Schmiedebergs Arch. Pharmacol. 353 1996 144
16. L.M. Gaster, F.E. Blaney, S. Davies, D.M. Duckworth, P. Ham, S. Jenkins, A.J. Jennings, G.F. Joiner, F.D. King, K.R. Mulholland, P.A. Wyman, J.J. Hagan, J. Hatcher, B.J. Jones, D.N. Middlemiss, G.W. Price, G. Riley, C. Roberts, C. Routledge, J. Selkirk, and P.D. Slade J. Med. Chem. 41 1998 1218
17. C. Ahlgren, A. Eriksson, P. Tellefors, S.B. Ross, C. Stenfors, and A. Malmberg Eur. J. Pharmacol. 499 2004 67
18. J. Watson, C. Roberts, C. Scott, I. Kendall, L. Collin, N.C. Day, M.H. Harries, E. Soffin, C.H. Davies, A.D. Randall, T. Heightman, L. Gaster, P. Wyman, C. Parker, G.W. Price, and D.N. Middlemiss Br. J. Pharmacol. 133 2001 797
19. J. Watson, M.J. Burton, G.W. Price, B.J. Jones, and D.N. Middlemiss Eur. J. Pharmacol. 314 1996 365
20. Marshall, H.; Thompson, M.; Wyman, P. A. WO2001023374.
21. Scott, C.; Langmead, C. J.; Wyman, P.; Smith, P. W.; Starr, K. R.; Dawson, L. A.; Price, G. W.; Watson, J. Neuropharmacology, submitted.
22. Dawson, L. A.; Hughes, Z. A.; Starr, K. R.; Storey, J. D.; Bettelini, L.; Arban, R.; Hagan, J. J.; Middlemiss, D. N.; Price, G. W. Neuropharmacology, submitted.